Literature DB >> 23593538

Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles.

Carsten Nieder1, Nicolaus H Andratschke, Anca L Grosu.   

Abstract

OBJECTIVES: Identification of the most influential scientific publications and directions of mainstream reirradiation research.
METHODS: A systematic search of the database Scopus (Elsevier B.V., www.scopus.com) was performed, which focused on the time period 1998-2010. Patterns of citation were analysed (total number of citations accumulated independently of their origin and proportion of highly cited articles, arbitrarily defined as those with ≥50 citations).
RESULTS: Up to 64 articles were published each year. Numbers increased over time, especially after the year 2007. Among all 76 articles with at least 50 citations, 28 (37%) focused on head and neck cancer, 27 (36%) on brain tumours including metastases, and 5 (7%) on bone metastases. Most articles evaluated external beam approaches while 10 (13%) focused on brachytherapy. Many of the often quoted publications reported on stereotactic and/or intensity-modulated radiotherapy. Two (3%) reported on randomised clinical studies and 10 (13%) on non-randomised prospective clinical studies (single institution or cooperative group). Only two articles (3%) reported on experimental animal studies.
CONCLUSIONS: The number of published reirradiation studies has increased in recent years. Many studies examined highly conformal and precise radiotherapy, in particular of brain and head and neck tumours. Given that few randomised clinical trials were published, efforts to increase this type of research activity are warranted.

Entities:  

Keywords:  Radiotherapy; citation; radiation oncology; radiation retreatment; reirradiation; research evaluation

Year:  2013        PMID: 23593538      PMCID: PMC3623835     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  62 in total

1.  Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.

Authors:  Carter Van Waes; Angela A Chang; Peter F Lebowitz; Colleen H Druzgal; Zhong Chen; Yusri A Elsayed; John B Sunwoo; Susan F Rudy; John C Morris; James B Mitchell; Kevin Camphausen; David Gius; Julian Adams; Edward A Sausville; Barbara A Conley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-11       Impact factor: 7.038

2.  Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma.

Authors:  R De Crevoisier; C Domenge; P Wibault; S Koscielny; A Lusinchi; F Janot; S Bobin; B Luboinski; F Eschwege; J Bourhis
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

Review 3.  Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

Authors:  Stuart J Wong; Mitchell Machtay; Yi Li
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

4.  Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.

Authors:  K S Chao; D A Low; C A Perez; J A Purdy
Journal:  Int J Cancer       Date:  2000-04-20       Impact factor: 7.396

Review 5.  How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

Authors:  P M Teo; W H Kwan; A T Chan; W Y Lee; W W King; C O Mok
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

6.  Salvage brachytherapy for localized prostate cancer after radiotherapy failure.

Authors:  G L Grado; J M Collins; J S Kriegshauser; C S Balch; M M Grado; G P Swanson; T R Larson; M M Wilkes; R J Navickis
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

7.  Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.

Authors:  B Emami; C Scott; C A Perez; S Asbell; P Swift; P Grigsby; A Montesano; P Rubin; W Curran; J Delrowe; H Arastu; K Fu; E Moros
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-03-15       Impact factor: 7.038

8.  Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

Authors:  R De Crevoisier; J Bourhis; C Domenge; P Wibault; S Koscielny; A Lusinchi; G Mamelle; F Janot; M Julieron; A M Leridant; P Marandas; J P Armand; G Schwaab; B Luboinski; F Eschwege
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

9.  Statistical validation of a global model for the distribution of the ultimate number of citations accrued by papers published in a scientific journal.

Authors:  Michael J Stringer; Marta Sales-Pardo; Luís A Nunes Amaral
Journal:  J Am Soc Inf Sci Technol       Date:  2010-07

Review 10.  The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mario Ammirati; Charles S Cobbs; Mark E Linskey; Nina A Paleologos; Timothy C Ryken; Stuart H Burri; Anthony L Asher; Jay S Loeffler; Paula D Robinson; David W Andrews; Laurie E Gaspar; Douglas Kondziolka; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Roy A Patchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-03       Impact factor: 4.130

View more
  10 in total

1.  When is re-irradiation in head and neck squamous cell carcinoma not indicated?

Authors:  Primož Strojan; Jonathan J Beitler; Carl E Silver; William M Mendenhall; Ashok R Shaha; Alessandra Rinaldo; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-09       Impact factor: 2.503

Review 2.  Prospective randomized clinical studies involving reirradiation : Lessons learned.

Authors:  Carsten Nieder; Johannes A Langendijk; Matthias Guckenberger; Anca L Grosu
Journal:  Strahlenther Onkol       Date:  2016-08-17       Impact factor: 3.621

3.  Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?

Authors:  Cynthia Wetmore; Danielle Herington; Tong Lin; Arzu Onar-Thomas; Amar Gajjar; Thomas E Merchant
Journal:  Cancer       Date:  2014-07-30       Impact factor: 6.860

4.  Reirradiation of Recurrent Pediatric Brain Tumors after Initial Proton Therapy.

Authors:  Benjamin Farnia; Nancy Philip; Rola H Georges; Mary Frances McAleer; Matthew Palmer; Jinzhong Yang; Pamela K Allen; Mary K Martel; Anita Mahajan; Susan L McGovern
Journal:  Int J Part Ther       Date:  2016-08-29

5.  Development of a score predicting survival after palliative reirradiation.

Authors:  Carsten Nieder; Nicolaus Andratschke; Kent Angelo; Ellinor Haukland; Anca L Grosu
Journal:  J Oncol       Date:  2014-09-21       Impact factor: 4.375

Review 6.  Preserving the legacy of reirradiation: A narrative review of historical publications.

Authors:  Carsten Nieder; Johannes A Langendijk; Matthias Guckenberger; Anca L Grosu
Journal:  Adv Radiat Oncol       Date:  2017-02-28

7.  A prospective phase II trial on reirradiation of brain metastases with radiosurgery.

Authors:  Ernesto Maranzano; Sara Terenzi; Paola Anselmo; Michelina Casale; Fabio Arcidiacono; Fabio Loreti; Alessandro Di Marzo; Lorena Draghini; Marco Italiani; Fabio Trippa
Journal:  Clin Transl Radiat Oncol       Date:  2019-04-13

Review 8.  Stereotactic radiosurgery (SRS) for brain metastases: a systematic review.

Authors:  Carsten Nieder; Anca L Grosu; Laurie E Gaspar
Journal:  Radiat Oncol       Date:  2014-07-12       Impact factor: 3.481

9.  Optimization of re-irradiation using deformable registration: a case study.

Authors:  Raphaël Jumeau; Nicolas Péguret; Cédric Zulliger; Raphaël Moeckli; Jean Bourhis; Esat-Mahmut Ozsahin
Journal:  BJR Case Rep       Date:  2016-05-06

10.  The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.

Authors:  Alexander Rühle; Tanja Sprave; Tobias Kalckreuth; Raluca Stoian; Erik Haehl; Constantinos Zamboglou; Roland Laszig; Andreas Knopf; Anca-Ligia Grosu; Nils H Nicolay
Journal:  Radiat Oncol       Date:  2020-04-16       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.